chr17_+_69939130
|
6.971
|
NM_022036
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C
|
chr3_-_150422474
|
6.512
|
NM_000096
|
CP
|
ceruloplasmin (ferroxidase)
|
chr6_+_131190237
|
6.354
|
NM_001195597
|
LOC285733
|
hypothetical LOC285733
|
chr4_+_69716298
|
6.077
|
NM_001075
NM_001144767
|
UGT2B10
|
UDP glucuronosyltransferase 2 family, polypeptide B10
|
chr3_-_71376919
|
5.200
|
|
FOXP1
|
forkhead box P1
|
chr12_+_119900931
|
5.193
|
NM_000545
|
HNF1A
|
HNF1 homeobox A
|
chr17_+_50699965
|
5.063
|
|
HLF
|
hepatic leukemia factor
|
chr3_+_152970904
|
5.029
|
|
LOC201651
|
arylacetamide deacetylase (esterase) pseudogene
|
chr12_-_51629874
|
4.885
|
|
KRT8
|
keratin 8
|
chr2_+_113601616
|
4.605
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
chr12_+_119900677
|
4.595
|
|
HNF1A
|
HNF1 homeobox A
|
chr6_-_41823056
|
4.534
|
NM_001166424
NM_002630
|
PGC
|
progastricsin (pepsinogen C)
|
chr2_+_113601608
|
4.382
|
NM_173842
|
IL1RN
|
interleukin 1 receptor antagonist
|
chr1_-_167822248
|
4.241
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
chr22_+_19458378
|
4.223
|
NM_000185
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1
|
chr4_+_6746466
|
4.206
|
NM_005980
|
S100P
|
S100 calcium binding protein P
|
chr1_-_167822334
|
4.182
|
NM_000130
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
chr16_-_86527608
|
4.063
|
NM_001739
|
CA5A
|
carbonic anhydrase VA, mitochondrial
|
chr14_-_37134050
|
3.996
|
|
FOXA1
|
forkhead box A1
|
chr1_-_176205672
|
3.801
|
NM_033127
|
SEC16B
|
SEC16 homolog B (S. cerevisiae)
|
chr5_+_132237253
|
3.615
|
NM_052971
|
LEAP2
|
liver expressed antimicrobial peptide 2
|
chr10_+_101532544
|
3.572
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
chr2_-_233586164
|
3.562
|
NM_019850
|
NGEF
|
neuronal guanine nucleotide exchange factor
|
chr12_-_9159707
|
3.411
|
|
A2M
|
alpha-2-macroglobulin
|
chr12_-_9159742
|
3.377
|
|
A2M
|
alpha-2-macroglobulin
|
chr2_-_233586145
|
3.362
|
|
NGEF
|
neuronal guanine nucleotide exchange factor
|
chr12_-_9159780
|
3.250
|
|
A2M
|
alpha-2-macroglobulin
|
chr10_+_7785360
|
3.153
|
|
ITIH2
|
inter-alpha (globulin) inhibitor H2
|
chr17_-_61655915
|
3.133
|
NM_000042
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
chr5_+_27508139
|
3.093
|
|
LOC643401
|
hypothetical protein LOC643401
|
chr10_+_7785347
|
3.078
|
|
ITIH2
|
inter-alpha (globulin) inhibitor H2
|
chr17_+_64922420
|
3.060
|
NM_002758
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
chr15_+_64661560
|
2.999
|
|
|
|
chr3_-_121883647
|
2.990
|
|
HGD
|
homogentisate 1,2-dioxygenase
|
chr10_+_7785235
|
2.946
|
NM_002216
|
ITIH2
|
inter-alpha (globulin) inhibitor H2
|
chr3_-_121884091
|
2.946
|
NM_000187
|
HGD
|
homogentisate 1,2-dioxygenase
|
chr10_+_7785290
|
2.931
|
|
ITIH2
|
inter-alpha (globulin) inhibitor H2
|
chr6_+_32003180
|
2.915
|
NM_000063
NM_001145903
|
C2
|
complement component 2
|
chr10_+_7785331
|
2.911
|
|
ITIH2
|
inter-alpha (globulin) inhibitor H2
|
chr10_-_54201400
|
2.868
|
NM_000242
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
chr1_-_57204208
|
2.801
|
NM_000066
|
C8B
|
complement component 8, beta polypeptide
|
chr2_-_165133239
|
2.715
|
|
GRB14
|
growth factor receptor-bound protein 14
|
chr1_-_1346465
|
2.714
|
NM_001145210
|
LOC441869
|
hypothetical protein LOC441869
|
chr1_-_229627412
|
2.700
|
NM_022051
|
EGLN1
|
egl nine homolog 1 (C. elegans)
|
chr3_+_187813553
|
2.699
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
chr17_-_23721351
|
2.673
|
|
VTN
|
vitronectin
|
chr5_+_147754467
|
2.651
|
|
FBXO38
|
F-box protein 38
|
chr10_+_101532450
|
2.616
|
NM_000392
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
chr4_-_186969202
|
2.603
|
NM_001145671
|
SORBS2
|
sorbin and SH3 domain containing 2
|
chr11_+_22652894
|
2.585
|
NM_005256
|
GAS2
|
growth arrest-specific 2
|
chr17_-_23721430
|
2.573
|
|
VTN
|
vitronectin
|
chr5_-_42847716
|
2.562
|
NM_001085486
NM_001093726
NM_005410
|
SEPP1
|
selenoprotein P, plasma, 1
|
chr4_+_39084936
|
2.485
|
|
KLB
|
klotho beta
|
chr6_-_26038817
|
2.423
|
NM_005835
|
SLC17A2
|
solute carrier family 17 (sodium phosphate), member 2
|
chr14_-_20563698
|
2.367
|
|
NDRG2
|
NDRG family member 2
|
chr7_+_116238309
|
2.354
|
|
CAPZA2
|
capping protein (actin filament) muscle Z-line, alpha 2
|
chr3_-_150569574
|
2.345
|
|
TM4SF1
|
transmembrane 4 L six family member 1
|
chr3_+_173043832
|
2.345
|
NM_001164436
|
TMEM212
|
transmembrane protein 212
|
chr11_-_117640078
|
2.335
|
|
|
|
chr1_+_16203317
|
2.321
|
NM_178840
|
C1orf64
|
chromosome 1 open reading frame 64
|
chr1_-_20682541
|
2.286
|
|
|
|
chr18_-_50777634
|
2.274
|
NM_025214
|
CCDC68
|
coiled-coil domain containing 68
|
chr12_+_99391870
|
2.267
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
chr14_-_20563722
|
2.267
|
NM_016250
NM_201535
NM_201536
NM_201537
|
NDRG2
|
NDRG family member 2
|
chr11_-_116168316
|
2.264
|
NM_001166598
NM_052968
|
APOA5
|
apolipoprotein A-V
|
chr17_-_6958695
|
2.263
|
|
ASGR2
|
asialoglycoprotein receptor 2
|
chr9_-_14900992
|
2.258
|
NM_144966
|
FREM1
|
FRAS1 related extracellular matrix 1
|
chr18_+_27425727
|
2.239
|
NM_000371
|
TTR
|
transthyretin
|
chr11_+_22652957
|
2.228
|
|
GAS2
|
growth arrest-specific 2
|
chr12_-_101835026
|
2.222
|
|
PAH
|
phenylalanine hydroxylase
|
chr7_+_94953148
|
2.220
|
NM_016116
NM_145872
|
ASB4
|
ankyrin repeat and SOCS box containing 4
|
chr14_+_87560646
|
2.187
|
|
LOC283587
|
hypothetical protein LOC283587
|
chr14_-_22358752
|
2.179
|
NM_001126106
|
SLC7A7
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 7
|
chr4_+_39084867
|
2.156
|
NM_175737
|
KLB
|
klotho beta
|
chr12_+_99391681
|
2.139
|
NM_005123
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
chr2_-_21084077
|
2.124
|
|
APOB
|
apolipoprotein B (including Ag(x) antigen)
|
chr3_+_187813538
|
2.120
|
NM_001622
|
AHSG
|
alpha-2-HS-glycoprotein
|
chr17_-_23721468
|
2.114
|
|
VTN
|
vitronectin
|
chr1_-_176205970
|
2.087
|
|
SEC16B
|
SEC16 homolog B (S. cerevisiae)
|
chr6_-_31953425
|
2.064
|
NM_001178045
|
SLC44A4
|
solute carrier family 44, member 4
|
chr17_-_23721420
|
2.014
|
|
VTN
|
vitronectin
|
chr12_-_9159789
|
2.002
|
NM_000014
|
A2M
|
alpha-2-macroglobulin
|
chr4_+_187424336
|
1.977
|
|
F11
|
coagulation factor XI
|
chr12_-_69837831
|
1.944
|
|
TSPAN8
|
tetraspanin 8
|
chr20_+_31334601
|
1.911
|
NM_033197
|
C20orf114
|
chromosome 20 open reading frame 114
|
chr14_-_93859394
|
1.885
|
NM_001756
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
chrX_-_55037235
|
1.855
|
NM_002625
|
PFKFB1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1
|
chr22_+_33792125
|
1.852
|
NM_001008494
|
ISX
|
intestine-specific homeobox
|
chr2_+_132196533
|
1.829
|
NM_013310
|
C2orf27A
|
chromosome 2 open reading frame 27A
|
chr10_+_102722275
|
1.827
|
NM_017893
|
SEMA4G
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G
|
chr21_+_39117064
|
1.826
|
|
ETS2
|
v-ets erythroblastosis virus E26 oncogene homolog 2 (avian)
|
chr17_-_23721485
|
1.821
|
NM_000638
|
VTN
|
vitronectin
|
chr17_-_36418869
|
1.740
|
NM_031958
|
KRTAP3-1
|
keratin associated protein 3-1
|
chr3_-_71715431
|
1.740
|
NM_001012505
NM_032682
|
FOXP1
|
forkhead box P1
|
chr20_+_41621079
|
1.729
|
NM_170693
|
SGK2
|
serum/glucocorticoid regulated kinase 2
|
chr2_-_135498716
|
1.718
|
NM_001018046
NM_025052
|
YSK4
|
YSK4 Sps1/Ste20-related kinase homolog (S. cerevisiae)
|
chr1_-_159459999
|
1.677
|
NM_001643
|
APOA2
|
apolipoprotein A-II
|
chr8_-_30121741
|
1.635
|
NM_001100916
|
MBOAT4
|
membrane bound O-acyltransferase domain containing 4
|
chr18_+_53863865
|
1.610
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like
|
chr3_+_187813405
|
1.595
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
chr12_-_69838045
|
1.592
|
NM_004616
|
TSPAN8
|
tetraspanin 8
|
chr10_-_44794146
|
1.590
|
NM_007021
|
C10orf10
|
chromosome 10 open reading frame 10
|
chrX_-_15198093
|
1.579
|
NM_001031739
NM_001168530
NM_024087
|
ASB9
|
ankyrin repeat and SOCS box containing 9
|
chr14_+_104337923
|
1.548
|
NM_001137601
|
ZBTB42
|
zinc finger and BTB domain containing 42
|
chr6_+_112481970
|
1.545
|
NM_003880
NM_198239
|
WISP3
|
WNT1 inducible signaling pathway protein 3
|
chr4_+_187424111
|
1.544
|
NM_000128
|
F11
|
coagulation factor XI
|
chr14_+_20226762
|
1.541
|
NM_001097577
NM_194431
|
ANG
RNASE4
|
angiogenin, ribonuclease, RNase A family, 5
ribonuclease, RNase A family, 4
|
chr9_-_115880494
|
1.513
|
NM_001633
|
AMBP
|
alpha-1-microglobulin/bikunin precursor
|
chr5_+_59819761
|
1.512
|
|
PART1
|
prostate androgen-regulated transcript 1 (non-protein coding)
|
chrX_-_106033202
|
1.491
|
NM_001171706
NM_138382
|
RIPPLY1
|
ripply1 homolog (zebrafish)
|
chr6_+_64414389
|
1.490
|
NM_015153
|
PHF3
|
PHD finger protein 3
|
chr1_-_205272619
|
1.475
|
NM_001083924
NM_023938
|
C1orf116
|
chromosome 1 open reading frame 116
|
chr10_-_69267774
|
1.475
|
NM_021800
NM_201262
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12
|
chr1_-_20179495
|
1.461
|
NM_000300
NM_001161727
NM_001161728
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
chr17_+_7423685
|
1.456
|
|
CD68
|
CD68 molecule
|
chr2_-_21120314
|
1.442
|
|
APOB
|
apolipoprotein B (including Ag(x) antigen)
|
chr17_+_7423704
|
1.440
|
|
CD68
|
CD68 molecule
|
chr17_+_7423662
|
1.436
|
|
CD68
|
CD68 molecule
|
chr22_-_25205376
|
1.435
|
NM_152841
|
HPS4
|
Hermansky-Pudlak syndrome 4
|
chr13_+_49658016
|
1.430
|
|
|
|
chr5_+_175908948
|
1.427
|
NM_017675
|
CDHR2
|
cadherin-related family member 2
|
chr2_+_11591692
|
1.406
|
NM_014668
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
chr3_-_49434874
|
1.386
|
|
AMT
|
aminomethyltransferase
|
chr21_-_42608531
|
1.378
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
chr17_-_6958773
|
1.367
|
NM_001181
NM_080912
NM_080913
|
ASGR2
|
asialoglycoprotein receptor 2
|
chr2_-_192420168
|
1.361
|
NM_004657
|
SDPR
|
serum deprivation response
|
chr5_-_59819642
|
1.346
|
NM_001165899
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
chr12_+_27740694
|
1.329
|
NM_001029874
|
REP15
|
RAB15 effector protein
|
chr19_-_63715135
|
1.284
|
NM_012254
|
SLC27A5
|
solute carrier family 27 (fatty acid transporter), member 5
|
chr1_-_150070849
|
1.281
|
NM_005060
|
RORC
|
RAR-related orphan receptor C
|
chr13_-_47885018
|
1.273
|
|
LPAR6
|
lysophosphatidic acid receptor 6
|
chr4_+_187385618
|
1.261
|
NM_000892
|
KLKB1
|
kallikrein B, plasma (Fletcher factor) 1
|
chr1_+_212228482
|
1.260
|
NM_002763
|
PROX1
|
prospero homeobox 1
|
chr2_-_32344192
|
1.259
|
NM_021209
|
NLRC4
|
NLR family, CARD domain containing 4
|
chrX_-_10761729
|
1.243
|
NM_033290
|
MID1
|
midline 1 (Opitz/BBB syndrome)
|
chr1_+_148496792
|
1.222
|
NM_012113
|
CA14
|
carbonic anhydrase XIV
|
chr20_+_31613800
|
1.222
|
NM_001039709
NM_005093
|
CBFA2T2
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 2
|
chr6_+_26359805
|
1.219
|
NM_003524
|
HIST1H2BH
|
histone cluster 1, H2bh
|
chr9_+_34643911
|
1.215
|
NM_004512
NM_147162
|
IL11RA
|
interleukin 11 receptor, alpha
|
chr17_+_38259620
|
1.213
|
|
AOC3
|
amine oxidase, copper containing 3 (vascular adhesion protein 1)
|
chr13_-_47885248
|
1.209
|
|
LPAR6
|
lysophosphatidic acid receptor 6
|
chrX_+_49718954
|
1.207
|
NM_000084
|
CLCN5
|
chloride channel 5
|
chr14_+_104338423
|
1.188
|
|
ZBTB42
|
zinc finger and BTB domain containing 42
|
chr17_+_7423528
|
1.184
|
NM_001251
NM_001040059
|
CD68
|
CD68 molecule
|
chr1_+_40486159
|
1.174
|
NM_001008740
|
TMCO2
|
transmembrane and coiled-coil domains 2
|
chr20_-_52120421
|
1.169
|
|
BCAS1
|
breast carcinoma amplified sequence 1
|
chr19_+_18357966
|
1.154
|
NM_004864
|
GDF15
|
growth differentiation factor 15
|
chr22_-_35835548
|
1.153
|
|
TMPRSS6
|
transmembrane protease, serine 6
|
chr7_-_50596238
|
1.123
|
NM_000790
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
chr1_+_15351885
|
1.118
|
|
TMEM51
|
transmembrane protein 51
|
chr6_-_32227695
|
1.112
|
NM_030651
|
PRRT1
|
proline-rich transmembrane protein 1
|
chr17_-_43390108
|
1.103
|
NM_024320
|
PRR15L
|
proline rich 15-like
|
chr8_+_18072250
|
1.092
|
NM_001160179
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
chr11_+_5431213
|
1.086
|
NM_001004754
|
OR51I2
|
olfactory receptor, family 51, subfamily I, member 2
|
chr1_+_15351585
|
1.086
|
NM_001136216
NM_001136217
|
TMEM51
|
transmembrane protein 51
|
chr7_+_113842470
|
1.085
|
|
FOXP2
|
forkhead box P2
|
chr2_+_173394560
|
1.083
|
NM_001100397
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4
|
chr1_-_177106702
|
1.070
|
NM_004673
|
ANGPTL1
|
angiopoietin-like 1
|
chr9_-_116305273
|
1.067
|
NM_001083885
|
DFNB31
|
deafness, autosomal recessive 31
|
chr2_-_20390601
|
1.064
|
NM_015317
|
PUM2
|
pumilio homolog 2 (Drosophila)
|
chr10_-_21847126
|
1.063
|
|
|
|
chr6_+_31731647
|
1.054
|
NM_019101
|
APOM
|
apolipoprotein M
|
chr2_-_39201631
|
1.054
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
chr1_-_159604287
|
1.049
|
NM_001013625
|
C1orf192
|
chromosome 1 open reading frame 192
|
chrX_-_131375217
|
1.049
|
NM_001170701
NM_001170702
NM_001170703
|
MBNL3
|
muscleblind-like 3 (Drosophila)
|
chr11_-_63690069
|
1.048
|
NM_014067
|
MACROD1
|
MACRO domain containing 1
|
chr14_+_38772870
|
1.040
|
NM_054024
|
MIA2
|
melanoma inhibitory activity 2
|
chr1_+_54132447
|
1.036
|
NM_000792
NM_001039715
NM_001039716
NM_213593
|
DIO1
|
deiodinase, iodothyronine, type I
|
chr7_+_99263571
|
1.030
|
NM_022820
NM_057095
NM_057096
|
CYP3A43
|
cytochrome P450, family 3, subfamily A, polypeptide 43
|
chr17_-_23757312
|
1.028
|
NM_080669
|
SLC46A1
|
solute carrier family 46 (folate transporter), member 1
|
chr4_-_40211324
|
1.020
|
|
RBM47
|
RNA binding motif protein 47
|
chr2_-_21120398
|
1.015
|
|
APOB
|
apolipoprotein B (including Ag(x) antigen)
|
chr5_+_76150637
|
1.014
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
chr2_-_21084911
|
1.013
|
|
APOB
|
apolipoprotein B (including Ag(x) antigen)
|
chr1_-_109651140
|
1.012
|
NM_001010985
|
MYBPHL
|
myosin binding protein H-like
|
chr4_+_74496575
|
1.008
|
|
ALB
|
albumin
|
chr1_-_57057956
|
1.007
|
NM_001004303
|
C1orf168
|
chromosome 1 open reading frame 168
|
chr11_+_22646229
|
1.000
|
NM_177553
|
GAS2
|
growth arrest-specific 2
|
chr20_+_41621119
|
0.996
|
|
SGK2
|
serum/glucocorticoid regulated kinase 2
|
chr11_-_6418705
|
0.994
|
NM_000613
|
HPX
|
hemopexin
|
chr2_-_21120420
|
0.992
|
NM_000384
|
APOB
|
apolipoprotein B (including Ag(x) antigen)
|
chr2_+_11597530
|
0.990
|
NM_148903
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
chr10_+_114144512
|
0.986
|
|
ACSL5
|
acyl-CoA synthetase long-chain family member 5
|
chr4_-_69852090
|
0.976
|
NM_024743
|
UGT2A3
|
UDP glucuronosyltransferase 2 family, polypeptide A3
|
chr10_+_685887
|
0.974
|
|
C10orf108
|
chromosome 10 open reading frame 108
|
chr1_-_150079656
|
0.965
|
NM_001136003
|
C2CD4D
|
C2 calcium-dependent domain containing 4D
|
chrX_+_99726445
|
0.954
|
NM_022144
|
TNMD
|
tenomodulin
|
chr3_-_124822113
|
0.949
|
NM_053031
NM_053032
|
MYLK
|
myosin light chain kinase
|
chr11_-_117628211
|
0.946
|
NM_198275
|
MPZL3
|
myelin protein zero-like 3
|
chr6_+_50789215
|
0.943
|
NM_172238
|
TFAP2D
|
transcription factor AP-2 delta (activating enhancer binding protein 2 delta)
|
chr5_+_92944680
|
0.938
|
NM_005654
|
NR2F1
|
nuclear receptor subfamily 2, group F, member 1
|
chr11_+_62893836
|
0.928
|
NM_080866
|
SLC22A9
|
solute carrier family 22 (organic anion transporter), member 9
|
chr15_+_94670160
|
0.921
|
NM_001145155
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2
|
chr1_+_74473672
|
0.918
|
NM_015978
|
TNNI3K
|
TNNI3 interacting kinase
|
chr11_-_63689780
|
0.911
|
|
MACROD1
|
MACRO domain containing 1
|
chr17_+_9686572
|
0.909
|
|
GLP2R
|
glucagon-like peptide 2 receptor
|
chr11_-_16953135
|
0.901
|
|
RPL36A
|
ribosomal protein L36a
|
chr2_+_241776596
|
0.895
|
NM_001001666
NM_001001891
|
ANO7
|
anoctamin 7
|
chr11_+_22644732
|
0.890
|
NM_001143830
|
GAS2
|
growth arrest-specific 2
|
chr17_-_74990157
|
0.880
|
NM_001082575
|
RBFOX3
|
RNA binding protein, fox-1 homolog (C. elegans) 3
|